The BMS Symposium is hosted by Professor Sergey Pronin and sponsored by Bristol Myers Squibb. It will feature lectures by Sarah Reisman of the California Institute of Technology and Natalie Holmberg Douglas of Bristol Myers Squibb.

2:00 PM: Introduction by Sergey Pronin

2:10 PM: Natalie Holmberg Douglas: “Discovery of BMS-986458, an Orally Bioavailable BCL6 Ligand-Directed Degrader”

3:10 PM: Reception Break